Viagra-Like Pill May Slow Alzheimer's
Key Points:
- A South Korean erectile dysfunction drug, sold as Mvix, showed modest success in slowing cognitive decline in a year-long trial involving over 1,500 early Alzheimer's patients, delaying decline by about three months compared to placebo.
- The drug's benefit was observed only in patients not using other dementia symptom treatments, and researchers believe the effect could increase with continued use.
- AriBio, the South Korean company behind Mvix, plans to seek FDA guidance on whether current data suffice for approval or if further trials are necessary.
- If approved, the low-dose, once-daily pill could provide a convenient at-home alternative to existing antibody infusions for Alzheimer's treatment.
- Experts caution that findings are preliminary, though some neuroscientists find the evidence promising, with previous studies suggesting similar benefits from related PDE5 inhibitor drugs like Viagra.